2022 Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Kavita Raj Journal Blood Cancer J.
2022 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Christian Koenecke Journal Bone Marrow Transplant.
2022 Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study Group Chronic Malignancies Working Party (CMWP) Transplant Complications Working Party (TCWP) 1st listed author Anna Waszczuk-Gajda Journal J Clin Med.
2022 Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Blood.
2022 Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author Bhagirathbhai Dholaria Journal Br J Haematol.
2022 Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Donal P McLornan Journal Br J Haematol.
2022 Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP Group Chronic Malignancies Working Party (CMWP) 1st listed author Francesco Onida Journal Bone Marrow Transplant.
2022 Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Edouard Forcade Journal Bone Marrow Transplant.
2022 Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019 Group Chronic Malignancies Working Party (CMWP) 1st listed author Dawn Swan Journal Br J Haematol.
2022 Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Joanna Drozd-Sokołowska Journal Bone Marrow Transplant.
2022 Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Laure Vincent Journal Bone Marrow Transplant.
2022 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Clin Cancer Res.